Proscia
AI-driven pathology analytics streamlining diagnostics and enhancing accuracy.. [Contact for Pricing]
Last verified:
What is Proscia?
Proscia is a software company accelerating pathology's transformation to a digital, data-driven discipline through its Concentriq enterprise pathology platform. The platform enables laboratories and life sciences organizations to convert glass slides into high-resolution whole slide images (WSIs), view them on computer screens, manage cases, share them remotely, and apply AI-powered computational analysis. Proscia's solution is FDA 510(k) cleared for primary diagnosis (Concentriq AP-Dx) and serves over 12,000 pathologists and scientists daily at diagnostic laboratories, academic medical centers, commercial labs, CROs, and 16 of the top 20 pharma leaders.
Key features include three purpose-built products: Concentriq LS for biomarker discovery and clinical trials in life sciences, Concentriq AP for 100% digital diagnosis in laboratories, and Concentriq AP-Dx for FDA-cleared primary diagnosis. The platform is hardware-agnostic and scanner-agnostic, integrating with all major whole slide image scanners including the Hamamatsu NanoZoomer S360MD. It offers open-architecture design that powers and integrates AI solutions developed by anyone, REST APIs for developers, cloud-based deployment options (Proscia-hosted cloud), bi-directional LIS integration, and Proscia Aperture for precision medicine insights at the moment of diagnosis.
Proscia is designed for pathologists, laboratory directors, IT teams, academic medical centers, health systems, commercial reference labs, life sciences companies (pharma and biotech), CROs, and researchers conducting biomarker discovery, translational research, toxicologic pathology, companion diagnostics development, and clinical trial enablement. The platform supports both clinical diagnostic workflows and research/life sciences use cases including spatial biology, tumor microenvironment analysis, and real-world evidence generation.
Proscia pricing
Pricing model: Freemium
Enterprise pricing only - no free tier available. Pricing details are not publicly disclosed on the website. Proscia offers custom enterprise pricing for academic medical centers, health systems, commercial labs, CROs, and pharmaceutical companies. The company offers a Concentriq LS package specifically for emerging biotechs and small/mid-sized CROs. Proscia-hosted cloud deployment is described as 'a fraction of the cost' compared to customer-hosted on-premise or customer-hosted cloud options. Prospective customers must contact Proscia directly to request pricing and connect with a digital pathology expert.
Proscia pros
- FDA 510(k) cleared for primary diagnosis (Concentriq AP-Dx)
- Rated #1 in 2026 Best in KLAS for Digital Pathology in Europe and Top Score in US
- Hardware-agnostic and scanner-agnostic - works with all major whole slide scanners
- Open-architecture platform that integrates AI solutions from any developer
- Over 12,000 pathologists and scientists use it daily
- 16 of the top 20 pharma leaders use Concentriq
- Cloud-based deployment available (Proscia-hosted cloud)
- Fast cloud deployment - up and running in just days
- Proscia-hosted cloud is fraction of cost vs on-premise or customer-hosted cloud
- 24/7 monitoring with near real-time alerting and response
- Bi-directional LIS integration for enterprise systems
- REST APIs and data warehouse for developers building AI models
- Concentriq Embeddings for AI-optimized digital foundation
- Scales automatically up or down based on workload
- Supports both clinical diagnostics and life sciences R&D on one platform
- Intuitive viewer that pathologists love with microscope-like navigation
- Near-zero major discordance rate (-0.1%) compared to glass slide reads
- Proscia Ready Partner Alliance with trusted scanner and AI partners
- ISO 27001 certified and Medical Device Single Audit Program certified
- Enables remote collaboration and distributed pathology work
Proscia cons
- No free tier available - enterprise pricing only
- Pricing details not publicly disclosed on website
- Concentriq AP-Dx cleared only with Hamamatsu NanoZoomer S360MD scanner in US
- Requires significant IT preparation for digital pathology implementation
- Cloud deployment requires contracting and professional services before setup
- AI accuracy depends on validation for specific use case and environment
- Digital pathology doesn't eliminate pathology staffing challenges
- Learning curve for labs transitioning from traditional microscope workflows
- Storage requirements are high (1-4 GB per whole slide image)
- Third-party AI integration requires platform familiarity
Frequently asked questions about Proscia
What is digital pathology?
Digital pathology is the practice of converting glass slides into high-resolution digital images (whole slide images) and using software to view, manage, share, and analyze those slides. Instead of relying solely on microscopes and physical slides, teams work with digital slides on a screen, enabling easier access, faster collaboration, remote work, and computational analysis including AI. Digital slides are created when glass slides are captured with a scanning device to provide high-resolution images viewable on computer screens or mobile devices.
What is a whole slide image (WSI) and why does it matter?
A whole slide image is a high-resolution digital scan of an entire glass pathology slide, typically reaching 1-3 gigapixels per slide and generating 1-4 GB of data. Unlike a static image, a WSI captures the full slide at multiple magnifications, allowing users to pan and zoom like navigating a map. WSIs are the foundation of digital pathology - once digitized, slides can be reviewed remotely, shared quickly, and analyzed with computational tools including AI.
Is Concentriq FDA cleared for primary diagnosis?
Yes. Proscia received FDA 510(k) clearance (K230839) for Concentriq AP-Dx for primary diagnosis in February 2024. The clearance is for clinical use with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States. A study demonstrated diagnoses on Concentriq AP-Dx are non-inferior to traditional glass slide reads, with a major discordance rate difference of -0.1% compared to ground truth.
What types of organizations use Concentriq?
More than 12,000 pathologists and scientists use Concentriq daily at diagnostic laboratories, academic medical centers, health systems, commercial reference labs, CROs (contract research organizations), and 16 of the top 20 pharmaceutical leaders. The platform serves both clinical operations (hospitals, labs) and therapeutic R&D (pharma, biotech, biotechs).
Is Concentriq compatible with different scanner brands?
Yes, Concentriq is scanner-agnostic and integrates with all major whole slide image scanners. The platform uses an open-architecture design that keeps scanners interchangeable across sites and use cases, avoiding vendor lock-in. This allows organizations to choose best-fit scanner components while maintaining Concentriq as a stable foundation.
How is AI used in Proscia's digital pathology platform?
AI builds on digital pathology and is designed to support pathologists, not replace them. AI assists with well-defined tasks such as detection, quantification, and spatial analysis of tissue features. Concentriq's open architecture integrates multiple AI applications including third-party tools directly into workflows. AI is best suited for narrow, structured tasks like cell detection, staining quantification, and measuring spatial features, while pathologists maintain human judgment for complex decisions.
What cloud deployment options does Proscia offer?
Proscia offers scalable, flexible cloud deployment options for research and diagnostic teams. Proscia-hosted cloud is fast to deploy (up and running in days after contracting), costs a fraction of customer-hosted on-premise or cloud options, includes 24/7 monitoring with near real-time alerting, and automatically scales up or down based on workload. Cloud deployment reduces time managing pathology data volume.
What is Concentriq LS used for?
Concentriq LS is the central hub for image-based scientific workflows in life sciences, from biomarker discovery to early-stage clinical trials. It transforms siloed pathology data into an AI-optimized digital foundation, enabling teams to leverage proprietary and real-world data with AI capabilities (Concentriq Embeddings). Common uses include biomarker discovery/validation, spatial biology, toxicologic pathology, companion diagnostics development, and clinical trial standardization.
How does digital pathology help with staffing challenges?
Digital pathology helps teams handle growing workloads and staffing constraints by enabling remote and distributed work (pathologists collaborate across sites), improving workflow efficiency (reducing manual slide handling time), providing scalability (rising volumes don't require linear staffing increases), and offering AI-assisted support to prioritize work and reduce variability. However, it doesn't eliminate staffing challenges entirely but helps teams work more sustainably.
What should teams prioritize when evaluating a digital pathology platform?
Teams should prioritize a platform built for pathologists with fast, intuitive, microscope-like navigation; open to scanners and AI with scanner-agnostic support and standards alignment; supporting multiple concurrent AI applications including third-party tools; proven bi-directional LIS integration for enterprise systems; and future readiness for research, real-world data, and life sciences use cases without separate platforms. A software-first approach (choosing software before scanners) helps avoid vendor lock-in.